4//SEC Filing
ALEXION PHARMACEUTICALS INC 4
Accession 0000899866-16-000243
CIK 0000899866operating
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 7:57 PM ET
Size
24.4 KB
Accession
0000899866-16-000243
Insider Transaction Report
Form 4
Carmichael Clare
SVP, Chief HR Officer
Transactions
- Award
Common Stock, par value $.0001 per share
2016-02-04+11,763→ 38,712 total - Sale
Common Stock, par value $.0001 per share
2016-02-08$138.02/sh−2,401$331,386→ 34,054 total - Sale
Common Stock, par value $.0001 per share
2016-02-05$143.58/sh−100$14,358→ 38,212 total - Sale
Common Stock, par value $.0001 per share
2016-02-05$142.15/sh−160$22,744→ 38,052 total - Sale
Common Stock, par value $.0001 per share
2016-02-04$143.81/sh−203$29,193→ 26,953 total - Sale
Common Stock, par value $.0001 per share
2016-02-04$145.13/sh−4$581→ 26,949 total - Sale
Common Stock, par value $.0001 per share
2016-02-05$145.38/sh−100$14,538→ 38,612 total - Sale
Common Stock, par value $.0001 per share
2016-02-05$144.33/sh−300$43,299→ 38,312 total - Sale
Common Stock, par value $.0001 per share
2016-02-05$141.42/sh−400$56,568→ 37,652 total - Sale
Common Stock, par value $.0001 per share
2016-02-05$140.44/sh−933$131,031→ 36,719 total - Sale
Common Stock, par value $.0001 per share
2016-02-08$138.02/sh−185$25,534→ 36,534 total - Sale
Common Stock, par value $.0001 per share
2016-02-08$139.13/sh−79$10,991→ 36,455 total
Footnotes (11)
- [F1]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
- [F10]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $138.00 - $138.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F11]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $139.00 - $139.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $143.00 - $143.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $145.00 - $145.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F4]On February 4, 2016, the Leadership and Compensation Committee determined that the reporting person earned 11,763 Performance Share Units upon achievement of certain performance targets previously established by the Committee. 1/3 of such shares vested on February 4, 2016 and 1/3 vest on each subsequent anniversary.
- [F5]This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units.
- [F6]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $144.00 - $144.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F7]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $142.00 - $142.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F8]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $141.00 - $141.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F9]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $140.00 - $140.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
Documents
Issuer
ALEXION PHARMACEUTICALS INC
CIK 0000899866
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000899866
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 7:57 PM ET
- Size
- 24.4 KB